Surging Prevalence of Neurological Illnesses is Escalating the Growth of the Vagus Nerve Stimulation market
Published: Nov, 2022
The surging prevalence of neurological illnesses such as epilepsy, depression, and migraine, as well as the increasing use of minimally invasive neurosurgery operations, are the prominent growth factors for the global vagus nerve stimulation market. According to WHO, about 50 million individuals worldwide suffer from epilepsy in 2019. Although medicine can control epilepsy, VNS therapy can be utilised as an adjunct treatment to control seizures. Similarly, according to the American Headache Society, migraine is one of the leading causes of disability in the United States and the third most common disease worldwide. In addition, an increasing number of approvals and new product launches are likely to boost market growth throughout the projection period. The introduction of new and innovative products by leading market participants is fueling global demand for and acceptance of VNS devices.
According to Marketlook Consulting’s research report “Global Vagus Nerve Stimulation Market Analysis, 2021”, the Global Vagus Nerve Stimulation market is anticipated to grow at a CAGR of 9% during 2022-29. The market would reach USD 1,147.5 Mn by 2029.
Based on Product, implantable VNS devices acquired a significant market share in 2021. Technological advancements in these implantable devices, which have resulted in device size reduction and timely programmed stimulation, among other benefits, have contributed to their domination in the global market.
“Global Vagus Nerve Stimulation Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Vagus Nerve Stimulation providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.
North America Dominated the Market
Based on Leading regions, North America dominated the global Vagus Nerve Stimulation market in 2021 and is projected to maintain its dominance during the forecasted period 2022-29 due to the region's market is distinguished by high rates of diagnosis and treatment for neurological problems, as well as suitable reimbursement regulations for VNS devices. These characteristics, together with increased patient awareness of novel treatment choices and the availability of modern VNS devices in the region, are responsible for the region's significant position in the global market. Moreover, rising incidences of respiratory diseases, growing urban populace and surging awareness among people and escalating expenditure on health and well-being products are projected to fuel the demand for Vagus Nerve Stimulation in the forthcoming period as stated in Marketlook Consulting research report “Global Vagus Nerve Stimulation Market Analysis, 2021”.
According to Marketlook Consulting’, the key players with a considerable market share in the global Vagus Nerve Stimulation market are Liva Nova PLC, Entero healthcare, Electro Core Inc., Beijing Medical Equipment, Boston Scientific Corporation, Cyberonics, Inc., NeuroMetrix, Inc, ImThera Medical, NERVANA LLC.
Market Segmentation:
- By Product (Implantable VNS Devices, External VNS Devices)
- By Biomaterial (Polymeric, Metallic, Ceramics)
- By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)
- By End Users (Hospitals, Ambulatory Surgical Centers (ASCS), Others)
- By Company (Liva Nova PLC, Entero healthcare, Electro Core Inc., Beijing Medical Equipment, Boston Scientific Corporation, Cyberonics, Inc., NeuroMetrix, Inc, ImThera Medical, NERVANA LLC)
Key questions answered in the study:
- What are the current and future trends of the Vagus Nerve Stimulation industry?
- How the industry has been evolving in terms of product and biomaterials?
- How the competition has been shaping across the countries followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the Vagus Nerve Stimulation industry?
- What is the customer orientation, purchase behavior, and expectations from the Vagus Nerve Stimulation firms across various regions?